Cargando…
Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy
Chemoresistance has long been the bottleneck of ovarian cancer (OC) prognosis. It has been shown that mitochondria play a crucial role in cell response to chemotherapy and that dysregulated mitochondrial dynamics is intricately linked with diseases like OC, but the underlying mechanisms remain equiv...
Autores principales: | Meng, Yang, Qiu, Lei, Zeng, Xinyi, Hu, Xiaoyan, Zhang, Yaguang, Wan, Xiaowen, Mao, Xiaobing, Wu, Jian, Xu, Yongfeng, Xiong, Qunli, Chen, Zhixin, Zhang, Bo, Han, Junhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731993/ https://www.ncbi.nlm.nih.gov/pubmed/36481655 http://dx.doi.org/10.1038/s41392-022-01253-y |
Ejemplares similares
-
NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
por: Xiong, Qunli, et al.
Publicado: (2023) -
The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance
por: Meng, Yang, et al.
Publicado: (2021) -
eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation
por: Zhang, Yaguang, et al.
Publicado: (2023) -
Small RNA modifications: regulatory molecules and potential applications
por: Xiong, Qunli, et al.
Publicado: (2023) -
The dual role of p63 in cancer
por: Xu, Yongfeng, et al.
Publicado: (2023)